| Cash Flow | 2025-10-31 |
|---|---|
| Net income | -250,806 |
| Depreciation and amortization | 103,444 |
| Loss (gain) on disposition of capital assets | -613 |
| Stock-based compensation | 3,685 |
| Deferred income tax | -18,535 |
| Charge for deferred loan costs and debt discount | 0 |
| Goodwill impairment charges | 302,284 |
| Gain on deal contingent foreign exchange forward currency contract | 0 |
| Noncash restructuring charges | 4,561 |
| Other, net | -7,114 |
| (increase) decrease in accounts receivable | 6,878 |
| Decrease in inventory | -23,553 |
| (increase) decrease in other current assets | 3,653 |
| Increase (decrease) in accounts payable | 3,313 |
| (decrease) increase in accrued liabilities | -9,657 |
| Increase (decrease) in current income taxes payable | 11,108 |
| (decrease) increase in other long-term liabilities | -4,693 |
| Other, net | 556 |
| Cash provided by operating activities | 164,897 |
| Acquisitions, net of cash acquired | 0 |
| Capital expenditures | 62,642 |
| Proceeds from disposition of capital assets | 634 |
| Cash used for investing activities | -62,008 |
| Borrowings under credit facility | 190,000 |
| Repayments of credit facility borrowings | 265,000 |
| Debt issuance costs | 0 |
| Repayments of other long-term debt | 4,045 |
| Common stock dividends paid | 14,889 |
| Issuance of common stock | 214 |
| Proceeds from deal contingent foreign exchange forward currency contract | 0 |
| Payroll tax paid to settle shares forfeited upon vesting of stock | 1,400 |
| Purchase of treasury stock | 32,360 |
| Cash (used for) provided by financing activities | -127,480 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -286 |
| (decrease) increase in cash, cash equivalents and restricted cash | -24,877 |
| Cash and cash equivalents at beginning of period | 102,995 |
| Cash and cash equivalents at end of period | 78,118 |
Quanex Building Products CORP (NX)
Quanex Building Products CORP (NX)